[go: up one dir, main page]

TR200200738T2 - Therapeutic removal of endometrial tissue outside the uterus, chronic lower abdominal pain and fallopian tube obstruction. - Google Patents

Therapeutic removal of endometrial tissue outside the uterus, chronic lower abdominal pain and fallopian tube obstruction.

Info

Publication number
TR200200738T2
TR200200738T2 TR2002/00738T TR200200738T TR200200738T2 TR 200200738 T2 TR200200738 T2 TR 200200738T2 TR 2002/00738 T TR2002/00738 T TR 2002/00738T TR 200200738 T TR200200738 T TR 200200738T TR 200200738 T2 TR200200738 T2 TR 200200738T2
Authority
TR
Turkey
Prior art keywords
abdominal pain
fallopian tube
uterus
lower abdominal
endometrial tissue
Prior art date
Application number
TR2002/00738T
Other languages
Turkish (tr)
Inventor
Engel Jurgen
Rieth-Muller-Winzen Hilde
Felberbaum Ricardo
Diedrich Klaus
K�Pker Wolfgang
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of TR200200738T2 publication Critical patent/TR200200738T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut bulus LHRH antagonistinin kisa süreli indükleme tedavisi ile yaklasik 4 ila 12 haftalik bir süre boyunca endometriyal dokunun rahim disi çogalmasi, kronik alt karin agrisi ve fallop tüpü tikanikliginin terapötik olarak giderilmesi için bir yöntem saglar.The present invention provides a method for therapeutic elimination of endometrial tissue prosthesis, chronic lower abdominal pain, and fallopian tube blockage for a period of approximately 4 to 12 weeks with short-term induction therapy of the LHRH antagonist.

TR2002/00738T 1999-09-23 2000-09-20 Therapeutic removal of endometrial tissue outside the uterus, chronic lower abdominal pain and fallopian tube obstruction. TR200200738T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15547899P 1999-09-23 1999-09-23

Publications (1)

Publication Number Publication Date
TR200200738T2 true TR200200738T2 (en) 2002-08-21

Family

ID=22555601

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00738T TR200200738T2 (en) 1999-09-23 2000-09-20 Therapeutic removal of endometrial tissue outside the uterus, chronic lower abdominal pain and fallopian tube obstruction.

Country Status (22)

Country Link
EP (1) EP1214086A2 (en)
JP (2) JP2003509467A (en)
KR (1) KR100772852B1 (en)
CN (2) CN1376070A (en)
AU (1) AU769482B2 (en)
BG (1) BG66128B1 (en)
BR (1) BR0014198A (en)
CA (1) CA2383510A1 (en)
HK (1) HK1049117A1 (en)
HU (1) HUP0202741A3 (en)
IL (1) IL148185A0 (en)
MX (1) MXPA02002436A (en)
NO (1) NO331198B1 (en)
NZ (1) NZ534836A (en)
PL (1) PL201898B1 (en)
RU (1) RU2255759C2 (en)
SK (1) SK3752002A3 (en)
TR (1) TR200200738T2 (en)
TW (1) TWI267373B (en)
UA (1) UA73956C2 (en)
WO (1) WO2001021194A2 (en)
ZA (1) ZA200201374B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10157628A1 (en) * 2001-11-26 2003-06-12 Zentaris Ag Solution for injection of an LHRH antagonist
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
WO2009094634A1 (en) 2008-01-24 2009-07-30 Esperance Pharmaceuticals Lytic domain fusion constructs and methods of making and using same
CA2750582A1 (en) * 2009-01-22 2010-07-29 Maatschap Interne Geneeskunde Rijnstate Method for the prophylaxis or treatment of flushing
AU2013337926B2 (en) 2012-10-30 2017-12-21 Esperance Pharmaceuticals, Inc. Antibody/drug conjugates and methods of use
CA2906894A1 (en) 2013-03-15 2014-09-18 Abbvie Inc. Compositions comprising elagolix for use in treating pain associated with endometriosis
WO2019036713A1 (en) 2017-08-18 2019-02-21 Abbvie Inc. Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome and adenomyosis
MX2020001877A (en) 2017-08-18 2020-09-14 Abbvie Inc Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis.
AU2018419533A1 (en) 2018-04-19 2020-11-12 Abbvie Inc. Methods of treating heavy menstrual bleeding
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
SE9301606D0 (en) * 1993-05-07 1993-05-07 Per-Christer Oden COMPOSITION FOR THE TREATMENT OF IMPAIRED HAIR GROWTH
US5658884A (en) * 1994-07-22 1997-08-19 The Medical College Of Hampton Roads Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
ATE190494T1 (en) * 1994-07-22 2000-04-15 Hampton Roads Medical College USE OF GNRH ANTAGONISTS FOR PRODUCING A MEDICATION FOR TREATING GONAD STEROID DEPENDENT DISEASES
DE19513662A1 (en) * 1995-04-08 1996-10-10 Schering Ag Combined pharmaceutical preparation for hormonal contraception
DE19604231A1 (en) * 1996-01-29 1997-07-31 Schering Ag Combined pharmaceutical preparation and its use for the treatment of gynecological disorders
RU2108583C1 (en) * 1996-07-29 1998-04-10 Николай Владимирович Рымашевский Method for determining indications to applying hormone therapy in genital endometriosis patients
EP0943336A1 (en) * 1996-09-04 1999-09-22 Dott Research Laboratory Peptide-containing pharmaceutical compositions for oral administration
WO1998055470A1 (en) * 1997-06-05 1998-12-10 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
DE19911771B4 (en) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH antagonist, process for its preparation and its use

Also Published As

Publication number Publication date
TWI267373B (en) 2006-12-01
NO20021430L (en) 2002-05-07
EP1214086A2 (en) 2002-06-19
ZA200201374B (en) 2002-10-30
NO331198B1 (en) 2011-10-31
CA2383510A1 (en) 2001-03-29
CN101045155A (en) 2007-10-03
WO2001021194A2 (en) 2001-03-29
PL201898B1 (en) 2009-05-29
AU769482B2 (en) 2004-01-29
PL353244A1 (en) 2003-11-03
UA73956C2 (en) 2005-10-17
BG66128B1 (en) 2011-06-30
AU7779200A (en) 2001-04-24
HUP0202741A3 (en) 2003-12-29
BG106584A (en) 2003-02-28
JP2003509467A (en) 2003-03-11
WO2001021194A3 (en) 2002-03-14
KR20020035879A (en) 2002-05-15
MXPA02002436A (en) 2003-02-12
KR100772852B1 (en) 2007-11-02
NO20021430D0 (en) 2002-03-21
HUP0202741A2 (en) 2003-01-28
JP2012051920A (en) 2012-03-15
IL148185A0 (en) 2002-09-12
RU2255759C2 (en) 2005-07-10
BR0014198A (en) 2002-05-21
CN1376070A (en) 2002-10-23
NZ534836A (en) 2007-07-27
HK1049117A1 (en) 2003-05-02
SK3752002A3 (en) 2003-06-03

Similar Documents

Publication Publication Date Title
BR0015284A (en) Controlled Release Hydrocodone Formulations
GB0013674D0 (en) Therapeutic use
PL366430A1 (en) Sustained release formulations of oxymorphone
DK0893998T4 (en) Delivery of nicotine into the large intestine for the treatment of inflammatory bowel diseases
CY1106763T1 (en) PREVENTIVE OR THERAPEUTIC MEANS FOR INFLAMMATORY BOWEL DISEASES
TR200200738T2 (en) Therapeutic removal of endometrial tissue outside the uterus, chronic lower abdominal pain and fallopian tube obstruction.
NZ517039A (en) Intravaginal clindamycin ovule composition, where the clindamycin is dispersed in a hard fat suppository base
NO20014519D0 (en) Apomorphine and Sildenafil Preparation
DK0998287T3 (en) Use of levobupivacaine
ES2164040T1 (en) USE OF AGONISTS OF THE GLICINE UNION SITE OR INHIBITORS OF GLYCIN ABSORPTION FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS.
BR0010869A (en) Method for administering a corticosteroid to a posterior segment of an eye and implantable sustained release device
HRP20020837B1 (en) HORMON COMPENSATION TREATMENT
BR0014996A (en) Method for preventing or ameliorating pain from a surgically closed wound in an individual, and, plaster
ATE320796T1 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ANAL INCONTINENCE AND ANAL ITCHING
PT1214077E (en) LOCAL LIBRARY OF 17-BETA ESTRADIOL TO IMPROVE THE VASCULAR FUNCTION OF ENDOTHELIA IN THE SEQUENCE OF VASCULAR WOUNDS
EE200200107A (en) Use of a fast-acting selective serotonin reuptake inhibitor in the manufacture of a medicament for the treatment of sexual dysfunction
PT1257292E (en) Use of il-18 inhibitors
ATE297732T1 (en) COMBINATION THERAPY FOR THE TREATMENT OF HEART FAILURE
BR0108865A (en) Methods of treating cancer and its associated pain using endothelin antagonists
SE9904424D0 (en) Use of interleukin-6 in combination with leptin in the treatment of obesity
EP1347754A4 (en) Compositions for adhesion prevention
TR200100670T2 (en) The use of R (+) - alpha- (2,3-Dimethoxyphenyl) -1- [2- (4-fluorophenyl) ethyl] -4-piperidinmethanol in the treatment of sleep disorders.
Gîscǎ et al. Scrotal urethrostomy in the dog-operating technique.
GR1003588B (en) Wheelchair of multiple use
EP1385497A4 (en) METHOD FOR PREVENTING OR TREATING BREAST CANCER, PROSTATE AND / OR COLUMN OF UTERUS USING N, N-DIMETHYLGLYCIN